瓦尔酸在体外模型评估神经发育毒性:一个范围审查
Daniel Sandvik1, Elena Vianca1,2, Alison Anderson1,3
1Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Victoria, Australia.
Epilepsia
|March 28, 2025
概括
酸 (VPA) 可能导致神经发育问题的胎儿酸谱障碍 (FVSD). 在体外研究中发现VPA.
科学领域:
- 神经科学和药理学 神经科学和药理学
- 发展性毒理学 发展性毒理学
- 的研究研究.
背景情况:
- 酸 (VPA) 是的关键一线抗发作药物 (ASM).
- VPA与致病性影响有关,导致胎儿氨酸谱系障碍 (FVSD),包括神经发育缺陷.
- 对于有生育能力的妇女来说,对VPA使用存在限制,即使对于那些对替代ASM反应不佳的妇女来说也是如此.
研究的目的:
- 系统地审查关于VPA对神经细胞影响的体外研究.
- 阐明VPA的拟议细胞神经毒性机制.
- 为患者制定改进的护理计划和新药设计提供信息.
主要方法:
- 对实验室研究的范围审查,调查VPA对神经细胞的影响.
- 对检查细胞毒性,异形性,遗传性和表观遗传性影响的研究进行分析.
- 包括来自小鼠和人类初级,永生和干细胞模型的数据.
主要成果:
- 在体外研究中确定了VPA对神经细胞的细胞毒性,异形性,遗传性和表观遗传性影响.
- 确定了许多与神经发育障碍相关的基因和途径,这些都是FVSD的特征.
- 缺乏标准化的方法阻碍了跨研究的直接比较,尽管人类干细胞模型提供了更深入的见解.
结论:
- 在体外研究提供了关于VPA的神经毒性和原性机制的宝贵数据.
- 人类干细胞模型增强了对VPA细胞,分子,遗传和表观遗传影响的理解.
- 未来对人类干细胞衍生神经细胞中临床相关的VPA度的研究可以改善女性的个性化治疗和药物设计.
更多相关视频
06:38Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach
Published on: June 11, 2017
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
相关概念视频
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...